What are you looking for?
Need help finding what you are looking for? Contact Us

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1348943

Cover Image

PUBLISHER: Greystone Research Associates | PRODUCT CODE: 1348943

Self-administered Injectable Drug Therapies and Markets

PAGES: 236 Pages
DELIVERY TIME: 1-2 business days
PDF (Single User License)
USD 4850
PDF (Site License)
USD 6500
PDF (Enterprise License)
USD 9000

Add to Cart

“Self-administered Injectable Drug Therapies and Markets” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, opportunities for injection devices that are designed for patient self-administration. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

Numerous graphs, charts, tables and visualizations complement the analysis.

Forecasts, projections of future market activity are derived using standard modeling and statistical techniques.

What You Will Learn:

  • Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.
  • Assesses key markets, market dynamics and market demographics.
  • Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.
  • Provides market data and forecasts.
  • Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations
  • Assesses the importance of alliances and partnerships on drug product commercialization.
  • Evaluates the impact of economic, technology, and regulatory factors
Product Code: SJDT338K

Table of Contents

Executive Summary

The Market Opportunity

Delivery Market Dynamics

  • The Economics of Injectable Drugs
  • What's Driving the Growth in
  • Injectable Devices?
  • Prefilled Syringes Proliferating
  • The Prefilled Syringe Supply Chain
  • The Trend toward Self-
  • Administration
  • Shifting Demographics
  • Innovation in Disposable Device
  • Designs
  • Proliferation of Biological Drugs

Therapeutic Monoclonal Antibodies

Injectable Drug Device Summaries

  • Autoinjectors
  • Single Fixed Dose
  • Variable Dosing
  • High Viscosity
  • Dual Chamber

Wirelessly Enabled Autoinjectors

  • Selected Product Specific Autoinjectors

Autoinjector Device Design Factors

  • Material Selection Issues
  • Part Counts and Device Cost
  • Safety Features
  • Needle Insertion Depth
  • Failsafe Activation
  • Dose Inspection/Injection Confirmation
  • Market Factors
  • Lyophilized Drugs/Reconstitution
  • Human Engineering/Ergonomics

Pen Injectors

  • Pen Injector Design Selection
  • Factors
  • Standardized Pen Platforms
  • Custom Pen Designs
  • Reusable Pens
  • Dual Chamber Pens

Commercial Pen Products

  • Hormones
  • Enzymes
  • Insulins
  • Detailed Profiles of 23 Devices

Wearable Devices - Analysis and Assessments

  • Libertas (Becton Dickinson)
  • SmartDose (West Pharmaceuticals)
  • Neulasta OnPro Injector (Insulet/Amgen)
  • YpsoDose (Ypsomed)
  • Electronic Semi-disposable
  • eLVD Patch Pump (Elcam)

Emerging Technology

  • Wireless Data

Injectable Drug Market Analysis and Forecasts

  • Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis
  • Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

  • Regulatory Issues
  • Device Branding
  • Patient Adherence and Ease of Use
  • Healthcare Economics

Company Profiles

Have a question?

Jeroen Van Heghe

Manager - EMEA



Christine Sirois

Manager - Americas


Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!